Bipolar disorder (BD) is a common neuropsychiatric disorder characterized by chronic recurrent episodes of depression and mania. Despite evidence for high heritability of BD, little is known about its underlying pathophysiology. To develop new tools for investigating the molecular and cellular basis of BD, we applied a family-based paradigm to derive and characterize a set of 12 induced pluripotent stem cell (iPSC) lines from a quartet consisting of two BD-affected brothers and their two unaffected parents. Initially, no significant phenotypic differences were observed between iPSCs derived from the different family members. However, upon directed neural differentiation, we observed that CXCR4 (CXC chemokine receptor-4) expressing central nervous system (CNS) neural progenitor cells (NPCs) from both BD patients compared with their unaffected parents exhibited multiple phenotypic differences at the level of neurogenesis and expression of genes critical for neuroplasticity, including WNT pathway components and ion channel subunits. Treatment of the CXCR4 + NPCs with a pharmacological inhibitor of glycogen synthase kinase 3, a known regulator of WNT signaling, was found to rescue a progenitor proliferation deficit in the BD patient NPCs. Taken together, these studies provide new cellular tools for dissecting the pathophysiology of BD and evidence for dysregulation of key pathways involved in neurodevelopment and neuroplasticity. Future generation of additional iPSCs following a family-based paradigm for modeling complex neuropsychiatric disorders in conjunction with in-depth phenotyping holds promise for providing insights into the pathophysiological substrates of BD and is likely to inform the development of targeted therapeutics for its treatment and ideally prevention.
INTRODUCTION
The precise relationship between the etiology and cellular pathophysiology of bipolar disorder (BD) remains poorly understood. [1] [2] [3] In light of its high heritability, 4, 5 genome-wide association studies (GWAS) have been used to identify genes and pathways associated with BD risk. Several GWAS and their metaanalyses have reported several genomic loci that meet the criteria of genome-wide significance. [5] [6] [7] However, despite these genetic efforts, the biological basis of BD remains elusive and the path toward highly effective, disease-modifying, targeted therapeutics is uncertain. Measurable brain pathology has had limited success as well; consistent neuroanatomical deficits have been difficult to identify. Some of the most consistent imaging results have implicated grey matter changes in both emotion and reward processing circuits. 8 Anatomical deficits such as these brain volume changes have prompted some researchers to label BD as a 'neurodevelopmental' disorder, but the basis for such neuro-developmental deficits has remained unclear. Other data that supports such a model implicate neural stem cell or neural progenitors. For instance, mutations in the DISC1 gene have been associated with several forms of mental illness in an extended Scottish pedigree, 9 including BD. 10 DISC1 has been shown to regulate neural progenitor proliferation through the inhibition of glycogen synthase kinase 3β (GSK3β), 11 a known target of the mood stabilizer lithium signaling. [12] [13] [14] Furthermore, antidepressant treatments have been shown to alter neural stem neurogenesis and plasticity. 15, 16 Thus, with what is proving to be a highly complex genetic landscape, modeling approaches investigating changes in single or small numbers of genes are incapable of capturing the full spectrum of factors that may impact pathophysiological processes relevant to BD.
In light of the need to examine genetically associated loci across a developmental continuum, and implication of neural stem cell neurogenesis in mood regulation, cellular models that allow access to different developmental stages would be invaluable to the further study of mood disorders. Fortunately, recent advances in human stem cell biology now provide the technology to create genetically accurate, patient-derived cellular tools through the reprogramming of somatic cells to a pluripotent state. Multiple central nervous system (CNS) lineages, including neurons and glia, can be derived from induced pluripotent stem cells (iPSCs) facilitating access to ex vivo characterization of patient-specific, cellular phenotypes that have otherwise been inaccessible. [17] [18] [19] Reflective of the increasing value of this strategy for human disease modeling, disease-specific, stem cell models have now been generated from multiple monogenic disorders using somatic cell reprogramming. [20] [21] [22] [23] [24] [25] [26] However, despite the potential for providing a basic human cellular model system and critically needed insight into the underlying pathophysiology, to date, only limited application of iPSC modeling has been performed in the context of complex genetic disorders. [27] [28] [29] [30] In the case of BD, recent analysis of common genetic variation associated with BD susceptibility using powerful genome-wide approaches has confirmed that BD is highly polygenic in nature, with the suggestion that there may be many thousands of common variants that contribute small or modest levels of risk for BD. 6 Thus, for modeling of BD with iPSCs choosing individuals at random would make it difficult to identify individuals, affected or unaffected, that do not harbor risk alleles, especially common variants associated with the disease, and the selection of a genetically appropriate control is problematic. Moreover, randomly selected BD patients might also be expected to harbor variants that only modestly affect cellular phenotypes in cellular models. Alternatively, consideration of family history and the number of risk alleles an individual might harbor (i.e. the genetic load) when selecting individuals for reprogramming may allow one to select individuals from a pedigree enriched for BD to enrich for deleterious alleles. Following this rationale, the more psychiatric disease in the family, the higher the genetic risk of any individual will be, and thus the greater the potential for enrichment of deleterious alleles and potentially observable in vitro cellular phenotypes. Furthermore, exploitation of familial relationships as part of iPSC model characterization enables the explicit prediction that the affected individuals will exhibit phenotypes not found in the unaffected family members. This prediction should become increasingly powerful for delineating true disease-specific phenotypes from patient-specific phenotypes as the size of the family increases. To begin to explore the potential utility of such a familybased paradigm for iPSC-based modeling of BD, which to date has not been applied to any human genetic disorder, here we generated and characterized 12 iPSC lines from a family with two unaffected parents and two BD male offspring. Overall, while no significant differences were observed between the 12 iPSCs, upon directed differentiation to the neural lineage, our studies revealed several neurodevelopmental phenotypes in both BD patient cells compared with the phenotypes of their unaffected parents. Additionally, specific defects in the expression of genes important for neurogenesis and neuroplasticity were observed, thereby pointing to new pathways to explore to understand the neural substrates of BD pathophysiology and providing new cellular tools for novel therapeutic discovery.
MATERIALS AND METHODS iPSC derivation and characterization
Fibroblast cell lines GM08330 (unaffected, father), GM08329 (unaffected, mother), GM05225 (BD Type I, proband) and GM05224 (BD Type I, brother) were obtained from the Coriell Cell Repository (Camden, NJ, USA). Records showed that punch biopsies for GM05224 and GM05225 were collected from the posterior iliac crest as were the two parents GM08330 and GM08329 (Dr E Gershon, personal communication). iPSCs were derived using individual pseudotyped retroviruses expressing MYC (MSCV-h-c-MYC-IRES-GFP; Addgene, Cambridge, MA, USA; cat. no. 18119), KLF4 (pMIG-hKLF4, Addgene; 17227), SOX2 (pMIG-hSOX2; Addgene; 17226) and OCT4 (pMIG-hOCT4; Addgene; 17225) packaged by Harvard Gene Therapy Core (Harvard Medical School, Boston, MA, USA) following methods described in Mostoslavsky et al. 31 Fibroblasts were infected with all four viruses as described 32 and split onto irradiated mouse embryonic fibroblasts (MEFs) (GlobalStem, Gaithersburg, MD, USA; GSC-6301G). Colonies were picked and expanded in hES media on MEFs or in mTeSR1 (StemCell Technologies, 05850; Vancouver, BC, Canada) on Matrigel (BD Biosciences, 354277; San Jose, CA, USA). hES media consisted of 80% DMEM/F12 (Life Technologies, Grand Island, NY; 11320033), 20% knock-out serum replacement (Life Technologies; 10828-028), 10 ng ml − 1 basic fibroblast growth factor (bFGF) (R&D Systems, Minneapolis, MN, USA; 233-FB-001MG/ CF), 1 mM L-glutamine (Life Technologies; 35050-061), 100 μM non-essential amino acids (Gibco, Grand Island, NY, USA; 11140-050), 100 μM 2-mercaptoethanol (Sigma, St. Louis, MO, USA; M6250), 50 U ml − 1 penicillin-50 mg ml − 1 streptomycin (Life Technologies; 15140-122).
Karyotyping
Cells were karyotyped by Cell Line Genetics (Madison, WI, USA) with standard Giemsa-stained chromosome spreads.
Teratoma formation iPSCs were grown on Matrigel/mTesR1 media. For teratoma formation, ∼ 10 7 iPSCs were pelleted and injected into SCID mice underneath the kidney capsule. Tumors were harvested after week 10 and analyzed using standard techniques, with interpretation by Frank H Lau (Cowan Lab, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA).
Genetic analysis
Genomic DNA was isolated using the DNAEasy Kit (Qiagen, Valencia, CA, USA; 69504). Fingerprinting was carried out by the Broad Institute Genomics Platform using the Fluidigm platform according to the manufacturer's instructions. Whole-genome single-nucleotide polymorphism (SNP) genotyping on 733 202 SNPs was carried out by the Broad Genomics Platform using Illumina OmniExpress arrays according to the manufacturer's instructions.
CNV analysis and validation
Copy number variants (CNVs) were detected using Birdsuite (version 1.6). 33 Events with LOD score (logarithm (base 10) of odds) ≥ 10 kb and size ≥ 10kb were lifted onto HG19 using the UCSC browser's lift over tool. These spanned~16 loci. One of these events (HG19: chr6: 78 973 201-79 029 367) overlaps a region of common CNVs in HapMap. 34 CNVs were validated with either commercially available or custom-designed TaqMan probes. Probes used were: 6p22.1, HG19: chr6: 29 859 709-29 896 421, Hs03587795_cn (Life Technologies), context sequence 5′-CAGGAGAATGTTCCTGCTGAGGACA-3′; Chr9, HG19: chr9: 7 734 481-7 770 942, Hs06879643_cn, context sequence 5′-AATAGCCTCATTACACCTTGCAAAT-3′; and 6q16.1, HG19: chr6: 95 486 777-95 578 465, probe primer 5′-TCCATAATCAGCGTGGCATA-3′, 5′ 6-FAM ZEN 3′Iowa Black FQ, forward primer 5′-TCAGGGTTGGTTTGCTTA TTG-3′, reverse primer 5′-CACCAATATATGTTCAAAGGGTCA-3′. Assays were carried out using digital droplet PCR (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions.
Identity-by-descent analysis
Using genotyping data generated by the Illumina Omni Express chip and PLINK, 35 SNPs were pruned using pairwise genotypic correlation to identify informative markers and then IBD (identity-by-descent) proportions were calculated between all individuals. IBD estimates were compared with expected values to affirm relationships between the family members. 36 
Multidimensional scaling analysis of SNP genotypes
For multidimensional analysis of SNP profiles, Family-811 quartet genotype data was merged with data from STEP and HapMap 2, and retained only those genotypes shared between all three data sets (N = 180 564). Using PLINK, linkage disequilibrium-based SNPs were pruned to 97 171 SNPs and then multidimensional scaling was run. Individuals from CEU (60) 
Fluorescence-activated cell sorting of neural progenitors
Conditions and fluorescence-activated cell sorting (FACS) parameters were based on work of Yuan et al. 37 Conjugated antibodies were purchased from BD Biosciences: CD184-APC (clone 12G5), CD271-PerCPy5.5 (clone C40-1457), CD24-PE (clone ML5) and CD15-FITC (clone HI98). FACS buffer consisted of 1 × Hank's buffered solution, 2% fetal bovine serum, 20 mM glucose, 1 × penicillin/streptomycin, 1 mM EDTA and was filtered and made fresh for each experiment. Accutase (Life Technologies; A11105-01), DNase I (Sigma; D4263) and 1 U μl − 1 DAPI (4',6-diamidino-2-phenylindole) (Life Technologies; D3571) was made at 2 mg ml − 1 in H2O. To obtain CD184 + , CD271 − , CD24 + , CD15 + cells, mixed NPC populations were either immunoselected using EasySep CD184 (Stemcell Technologies) according to the manufacturer's instructions and FACSed or directly FACSed. For preparing cells for FACS, 0.5-2 × 10 7 cells were washed once with DMEM/ F12 and dissociated with Accutase at 37°C for 5 min. FACS buffer was added to terminate digestion and cells were triturated to form a single-cell suspension. Cells were then washed two times with FACS buffer and resuspended at a concentration of 1 × 10 7 cells per ml. DNAse I was added to a final concentration of 100 U ml − 1 and the suspension was incubated at room temperature for 10 min. Cells were stained immediately. A total of 1 × 10 7 cells per ml were stained for 20 min at 4°C with the respective single conjugated antibodies or all four conjugated antibodies with dilutions consisting of 1 : 12 CD184, 1 : 20 CD271, 1 : 12 CD24 and 1 : 12 CD15. Cells were washed once in FACS buffer and resuspended in 500 μl for single-color staining and 1-2 ml for four-color staining. Cells were maintained at 4°C until ready for sorting using a four-color sorting protocol on a FACS Aria cell sorter to obtain CD184 + , CD271 − , CD15 + , CD24 + cells (BD Biosciences). A gating protocol was established in which CD184 + CD271 − cells were separated into CD24 + and CD15 + containing populations. Cells were sorted directly into Neurobasal media at room temperature using a 100 μm nozzle, 20 psi sheath pressure and 2000 events s − 1 , taking care not to subject the cells to excessive shear forces that would reduce viability. Cells were plated with ROCK inhibitor (10 ng ml − 1 ) at a concentration of 1-4 × 10 5 cells in one well of a sixwell plate or 0.5-0.9 × 10 5 cells in one well of a 12-well plate.
Neuralized embryoid body formation iPSCs were grown on MEFs or Matrigel to confluence. iPSCs were dissociated with Accutase (Life Technologies; A11105-01). The 3000-6000 single cells were placed in Aggrewell 400 plates (Stemcell Technologies; 27945) and incubated in hES media without FGF for 24 h. Aggregates were released and passed through the 40 μm cell strainer to remove single cells. One thousand aggregates per well were plated in an ultra-low adherence 6-well plate (Corning, Tewksbury, MA, USA; 3471) in neural induction medium on day 0. Neuralized embryoid bodies (nEBs) were fed every other day and harvested on days 1 and 11 for further analysis. RNA was isolated from EBs using the MicroRNAeasy Kit (Qiagen; 217004).
Lineage scorecard analysis
iPSCs were cultured and dissociated as described for nEBs above. nEBs were formed in hES media without FGF for 16 days, with media changes every 2 days. nEBs were harvested and RNA was collected using a MicroRNAeasy Kit (Qiagen; 217004). Lineage scorecard was calculated for nondirected EB differentiation using the NanoString probe set described by Bock et al. 38 after quantification using single-molecule imaging on an nCounter System according to the manufacturer's instructions by the Meissner Lab at Harvard University (Cambridge, MA, USA).
Neuronal differentiation
Cells were dissociated into a single-cell suspension with TrypLE (Life Technologies; 12604-013) or Accutase and 3 × 10 4 NPCs were plated on glass coverslips coated with 10 μg ml − 1 laminin (Sigma; L2020) and 15 μg ml − 1 polyornithine (Sigma; P4957) in Neurobasal media (Life Technologies; 21103-049) containing 200 μM ascorbic acid, 0.5 mM dibutyryl cAMP (Sigma; D0260) and 1 mg ml − 1 laminin, 20 ng ml − 1 brain-derived neurotrophic factor (PeproTech, Rocky Hill, NJ, USA; 450-02) and 20 ng ml − 1 glial cell line-derived neurotrophic factor (PeproTech; 450-10). Cells were fed every 2-3 days until ready for immunostaining and/or electrophysiology.
Immunostaining
Cells were washed with phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde at room temperature for 15-20 min and permeabilized with 100% ethanol for 2 min at room temperature. Fixed cells were blocked in 4% bovine serum albumin, 0.1% Triton X-100 in PBS at room temperature for 1 h. Primary antibodies diluted in 0.5% bovine serum albumin, 0.1% Triton X-100 in PBS and incubated overnight at 4°C. Following incubation, cells were washed three times for 5 min each in PBS and then incubated with secondary antibody Alexa Fluor 488-conjugated goat anti-mouse antibodies (1:500; Life Technologies; A11017), Alexa Fluor 555-conjugated goat anti-rabbit (1:500; Life Technologies, A21430) and Alexa Fluor 647conjugated goat anti-chicken antibodies (1:500; Life Technologies, A21449) for 1 h at room temperature. Cells were washed three times in PBS and subsequently mounted onto glass slides with prolong gold antifade reagent with DAPI (Life Technologies; P36931). Immunofluorescence was visualized with Nikon Eclipse 80i fluorescent microscope (Nikon, Tokyo, Japan). The following primary antibodies were used: TuJ1 (anti-β-tubulin III; 1:500; Sigma; T2200), MAP2 (1:10 000; Chemicon, Billerica, MA, USA; AB5622) and GFAP (1:200; Sigma; G3893) (data not shown).
NanoString digital mRNA expression profiling RNA was isolated using the miRNAEasy Kit (Qiagen; 217004) according to the manufacturer's instructions. One hundred nanograms of total RNA from each sample was profiled using single-molecule imaging on a Nanostring nCounter System (Nanostring Technologies, Seattle, WA, USA) according to the manufacturer's instructions by the Genomics Platform at the Broad Institute (Cambridge, MA, USA) using a 352 probe custom PsychGene probe set consisting of genes to profile pluripotency, differentiation, WNT signaling and candidate genes previously associated with either BD or schizophrenia (Supplementary Table 7 ). Data were normalized using spiked-in positive and negative control genes and the VSN algorithm. 39 Differentially expressed genes were identified using the Bioconductor module limma. 40 
RNA-seq transcriptome analysis
RNA was isolated using the miRNAEasy Kit (Qiagen; 217004) according to the manufacturer's instructions. All libraries were molecularly barcoded using TruSeq adaptors (Illumina, San Diego, CA, USA) and sequenced on a HiSeq2000 (Illumina) using paired-end 75 cycle reads. The assembly of transcript estimation of their abundances and tests for differential expression were performed using Tophat (transcriptome version: Ensembl Homo_sapiens.GRCh37.73.gtf) and Cufflinks-Cuffdiff v.1.0 41 (transcriptome version: Illumina's igenomes Ensembl GRCh37). To increase statistical power, FPKM (fragments per kilo bases of exons for per million mapped reads) values were averaged from both parental control CXCR4+ NPC samples and both replicates of the BD patient CXCR4+ NPCs GM05224.
Only transcripts with sufficient read depth in both conditions, as determined by Cuffdiff analysis, were considered in subsequent analysis.
BrdU incorporation assays of DNA replication
Cells were plated on polyornithine/laminin-coated coverslips and grown for 2 days. Bromo-deoxyuridine (BrdU) (Sigma; B5002) was added to a final concentration of 10 μM for 2 h at 37°C. Cells were fixed in 2% paraformaldehyde for 15 min at room temperature and then permeabilized in 95% methanol for 20 min at − 20°C. DNA was denatured with 2 N HCl at room temperature for 10 min and neutralized in 0.1 M borate buffer (pH 8.5) for 10 min. Cells were blocked in 5% goat serum/0.2% Triton X-100/1% bovine serum albumin/PBS at room temperature for 30-60 min. Cells were stained with mouse anti-BrdU (1:100; Sigma; B8434) and rabbit anti-NESTIN (1:2000; R&D Systems; MAB1259) antibodies. Cells were then stained with secondary antibodies goat anti-mouse Alexa Fluor 488 and goat anti-rabbit Alexa Fluor 555 (Life Technologies; A21428). Coverslips were mounted with Vectashield and imaged. In three independent experiments, 300-500 cells were counted and percent BrdU incorporation was calculated as the total BrdU-positive cells divided by the total NESTIN-positive cells in a field. Statistical significance was calculated using analysis of variance. CHIR-99021 effects on proliferation were measured in parallel cell cultures and were treated with dimethyl sulfoxide (vehicle) and CHIR-99021 (custom synthesized as for Pan et al. 42 ) at a final concentration of 5 μM for 16 h before BrdU labeling. Electrophysiology Cells were differentiated as described above. Standard patch-clamp recordings were carried out using an extracellular solution (in mM) consisting of 115 NaCl, 2 KCl, 3 CaCl2, 10 glucose, 1.5 MgCl2 and an intracellular (in mM) consisting of 140 potassium gluconate (C6H11KO7), 5 KCl, 2 MgCl2, 10 HEPES, 0.2 EGTA, 2.5 Na-ATP, 0.5 Na-GTP and 10 Na2 phosphocreatine. Voltage-activated currents were recorded in the voltageclamp configuration using an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA, USA) and head stage. Series resistance was compensated up to 80%. Action potentials were recorded in the current clamp configuration on the Axopatch 200B. Data were acquired using pClamp10 (Molecular Devices) at a rate of 10 kHz filtering at 5 Hz. Data were analyzed using pClamp software and custom scripts written in Igor (Wavemetrics, Lake Oswego, OR, USA).
Network analysis, clustering and gene ontology analysis
Agglomerative hierarchical clustering with a weighted pair-group average was performed using a Pearson's correlation coefficient as the similarity metric on the matrix of NanoString PsychGene probes that showed statistically significant differential expression in either the NPCs or neurons comparing the BD and unaffected parental control samples with XLSTAT (v.2014.3.02). Disease Association Protein-Protein Link Evaluator (DAPPLE) v.2.0 was run using the web-based tool available at http: //www. broadinstitute.org/mpg/dapple/dappleTMP.php. The resulting direct and indirect network was constructed. Of the input seed list of 53 differentially expressed genes, 43 were mappable by DAPPLE, whereas a subset of genes that were also differentially expressed (C4ORF45, CACNG8, FNIP2, HLA-B, IRX3, NKX2.2, NKX6.1, POTED, SOX5, VEPH1) were not. The P-value for the global network parameters and individual P-values for seed proteins representing the probability that by chance the seed protein would be as connected to other seed proteins (directly or indirectly) as is observed were calculated with 5000 within-degree, node-label permutations. For gene ontology (GO) analysis of RNA-sequencing (RNA-seq) profiles, DAVIDv.6.7 bioinformatics software (http://david.abcc.ncifcrf.gov/, NIAID, NIH, MD, USA) was used to determine GO categories with significant representation (Po0.05, Benjamini-Hochberg corrected).
RESULTS
We selected a subset of four individuals from a multigenerational kindred, Family-811 with bipolar disorder originally described by Gershon et al. 43 (Figure 1a ). This subset, referred to here as the 'Family-811 quartet', consisted of an unaffected father (GM08330) and mother (GM08329) and their two sons with BD (GM05225 and GM05224) ( Figure 1a and Supplementary Table 1 ). Whole-genome SNP profiling of 733 202 markers was performed on fibroblast DNA. Analysis of these data using inheritance by descent measures confirmed the expected parent-child and sibling relationships of the Family-811 quartet (Figure 1b and Supplementary  Table 2 ), and using multidimensional scaling analysis showed that the quartet clusters with the Northern and Western Europe (CEU) individuals from HapMap (Figure 1c ).
To annotate the genomes of Family-811 quartet with genetic variants of potential relevance to neuropsychiatric disorder etiology, we analyzed the whole-genome SNP profiles of the Family-811 quartet and confirmed the SNP genotypes of a subset of the peak risk variants from the most recent Psychiatric Genetics Consortium GWAS ( Supplementary Table 3 ). These targeted genotyping assays indicated that all four Family-811 members were homozygous reference for the BD risk allele in SYNE1 and ANK3 (Ankyrin 3). GM08329 (mother) was heterozygous for the risk allele of CACNA1C (calcium channel, voltage-dependent, l-type, α1C subunit), whereas the remaining family members were homozygous reference for the BD risk allele. All family members in the quartet were heterozygous reference for the BD risk allele in ODZ4 (odd Oz/ten-m homolog 4; TNM4), except GM05225 who was a homozygous reference. Finally, all family members were found to be heterozygous reference for a ZNF804A (zinc-finger protein 804A) schizophrenia risk allele.
Using the whole-genome SNP data, with a criteria of LOD score 410 and a size 410 kb, 33 several CNVs were identified that segregated from parent to offspring (Figures 1d and e, Supplementary  Tables 4 and 5 and Supplementary Figure 1 ). One CNV 4100 kb was identified in cytoband 9p24.1, near, but not identical, to a region previously identified in scans of psychiatric disorder patients by Malhotra et al. 44 Three of the CNVs (6q16.1, 6q22.1 and 9p24.1) were subsequently validated in DNA isolated from lymphoblastoid cell lines from the Familly-811 quartet. Overall, these genomic data are consistent with the ethnicity of previous descriptions of members of Family-811, and it revealed that the BD patients contained no detectable large (410 kb) de novo structural genomic variants unique to both BD patients, suggesting that CNVs of this nature are unlikely to influence any observed cellular phenotypes unless introduced spontaneously during reprograming.
iPSC generation, characterization and neural differentiation from Family-811 Using classical Yamanaka factors 17 (OCT4, SOX2, KLF4 and cMYC) delivered in retroviral vectors, at least three iPSC colonies from each fibroblast line from all four Family-811 quartet members were isolated, expanded and fully characterized. All 12 iPSC lines were picked from primary iPSC colonies before any splitting and were expanded separately and thus can be considered independent iPSCs lines. Karyotype analysis indicated all 12 iPSCs were normal ( Supplementary Figure 2) , and a 23 SNP marker panel used for fingerprinting iPSCs postreprogramming corresponded to their respective parental fibroblast lines (data not shown). Pluripotency of all 12 iPSC lines from the quartet was initially assessed through the measurement of a panel of characteristic pluripotency markers, including NANOG, OCT4, SSEA-4, Tra-1-60 and Tra-1-81 ( Supplementary Figure 3) . As a further test of pluripotency, genome-wide transcriptome profiles were generated from all 12 iPSCs and PluriTest, a bioinformatic assay that uses global gene expression profiles to bench mark unknown iPSCs with bona fide pluripotent cells, 45 was performed. The results of the PluriTest confirmed that the 12 iPSCs were highly similar in their transcriptome to previously described pluripotent stem cells ( Supplementary  Figure 4 ). Finally, pluripotency was directly assessed by determining the ability of all 12 iPSCs lines to form teratomas in nude mice. Upon sectioning and hematoxylin and eosin staining, teratomas from all 12 iPSCs were found to contain representative tissue of all three (ectoderm, mesoderm and endoderm) germ layers (Supplementary Figure 5 ). Collectively, these data demonstrate successful generation of 12 high-quality, independent iPSC lines (picked from unique primary iPSC clones) from a family with BD.
To more specifically investigate the in vitro neural differentiation capacity of each of the 12 iPSCs lines from the Family-811 quartet, directed neural differentiation was used to generate NPCs. To initially derive heterogeneous populations of NPCs containing both CNS and peripheral nervous system progenitors, each of the 12 iPSC lines were cultured individually on MEF feeder cells and colonies were passaged manually to feeder-free cultures on Matrigel in the presence of bFGF. After 3 days, bFGF was withdrawn to induce differentiation, and after 7 days, the media were switched to neural induction media consisting of Neurobasal media supplemented with B27 (without retinoic acid), EGF and bFGF. All 12 of the iPSC lines, regardless of whether they were from the healthy control parents or BD sons, were found to be capable of forming neural rosettes with a morphology characteristic of early neuroepithelium, which upon picking and expansion on polyornithine/laminin-coated plates gave rise to self-renewing NPCs that stained for a panel of markers, including SOX1 (SRY-box containing gene 1), SOX2, NESTIN and MUSASHI (Figure 2a and data not shown).
Next, to create more homogenous populations of NPCs that were enriched for CNS progenitors, the initially mixed NPC cultures were immunopurified using a four-color, FACS protocol designed to remove non-neural cells and cells expressing CD271 (p75; NGFR), a marker of neural crest cells that produce peripheral nervous system cells and select for CD184 (CXC chemokine The familial relationship of these individuals was confirmed using identity-by-descent (IBD) analysis. The IBD1 and IBD2 components were plotted for the parent-parent, parent-offspring and offspring-offspring comparisons. Each of these comparisons agreed with the theoretic prediction of allele sharing for the given familial relationship ((IBD0, IBD1): parentparent = (1,0); siblings = (1/4,1/2); parent-sibling = (0,1)). 36 receptor-4 (CXCR4)) expression as a marker of CNS progenitors (Figure 2b and Supplementary Figure 6 ). 37 Whereas self-renewing, CD184 + /CD271 − /CD24 + /CD15 + cells capable of expansion for more than five passages could be readily established from both the mother and father, neural induction of iPSCs from both BD patients repeatedly produced more peripheral nervous system progenitors than CNS progenitors, as defined by immunostaining for CD271 and CD184 markers, respectively ( Supplementary  Figure 7) . Consistent with this phenotype, despite repeated attempts under varied neural induction conditions, CD184 + /CD271 − /CD24 + /CD15 + immunopurified NPC lines could only be successfully established beyond five passages from a subset of the BD patient iPSC lines. Of the successfully FACS-purified NPC lines expressing CD184 + , all had characteristic NESTIN+ cell morphology, proliferated in a monolayer in the presence of EGF and bFGF, and upon mitogen removal differentiated into MAP2 + and βIIItubulin + (Tuj1 + ) neurons capable of firing action potentials (Figures 2b and c and Supplementary Figure 8 ). Thus, as summarized in the lineage diagram shown in Figure 2d , we were able to generate expandable (greater than five passages), FACSimmunopurified, CXCR4 + NPC lines from all six of the parental iPSC lines and only one of three iPSC lines from each BD-affected son within the Family-811 quartet.
The successful generation of expandable CXCR4 + NPCs lines from the parental control iPSCs and one iPSC from each of the BDaffected sons within the Family-811 quartet afforded the opportunity, for the first time, to characterize the molecular and cellular phenotypes in a defined CNS progenitor cell (i.e. CXCR4 + ) and postmitotic neurons derived from them upon neural differentiation. Initially, using BrdU incorporation into DNA to Each of the iPSC lines generated from the Family-811 quartet was capable of generating neural rosettes with a characteristic morphology that were manually dissected, passaged and expanded in culture. Each of the iPSC lines was capable of generating SOX1 + cells that could be expanded in vitro. (b) To derive comparable populations of neural progenitor cells (NPCs), a cell surface signature described by Yuan et al. 37 was used with fluorescence-activated cell sorting (FACS) to isolate CD184 + /CD271 − /CD24 + /CD15 + cells. A representative gating scheme and plot of the events for an experiment is shown. Representative images of CD184 + /CD271 − /CD24 + /CD15 + cells from GM08330, GM08329, GM05225 and GM05224 stained for NESTIN (red) and DAPI (4',6-diamidino-2-phenylindole; blue) for DNA. (c) FACS-purified NPCs from the iPSC lines indicated were differentiated into neurons for 6 weeks, yielding postmitotic neurons staining for the neuronal markers TuJ1 and MAP2. (d) A cell lineage diagram summarizes the cells and cell lines generated from fibroblasts and iPSCs from each of the individuals in the Family-811 quartet. X's indicate NPC lines that were able to be initally isolated but were unable to be continually expanded beyond four or five passages in vitro despite mutliple attempts. The scale bar is 100 μm. measure cell proliferation, we observed a proliferation deficit in both of the BD patient NPCs compared with the unaffected parental NPCs (Figures 3a and b ) (t-test, P = 0.001). In addition to this proliferation defect, both BD patient NPCs produced qualitatively fewer βIII-tubulin (Tuj1 + ) neurons than the unaffected NPCs over a 6-week differentiation time course (Figure 3c ). Taken together, these observations, and the difficulty encountered in generating CXCR4 + NPCs from neural rosettes by FACS, collectively provided initial evidence for a neural differentiation deficit phenotype in both BD patient NPCs from the Family-811 quartet that ultimately negatively impacts ex vivo neurogenesis.
NanoString molecular profiling of iPSCs, NPCs and neurons from Family-811 Having observed a neurogenesis deficit from the BD patient iPSCs, to ensure that the differentiation deficit did not represent a general differentiation defect of the iPSCs, we turned to an evaluation of the overall differentiation capacity of all 12 of iPSCs from the Family-811 quartet that we had generated. For these measurements, three independent iPSCs lines from each of the unaffected parents (6 lines total) and three independent iPSCs lines from the BD sons were grown (6 lines total) for 16 days under non-directed differentiation conditions and total RNA was isolated. The expression of a panel of 500 genes designed by Bock et al. 38 as a 'scorecard' to define quantitatively the differentiation capacity of human embryonic stem cells/iPSCs of unknown developmental capacity was then assessed using NanoString digital mRNA expression profiling technology, a highly sensitive, single-molecule imaging of color-coded, molecular barcoded probes (Supplementary Table 6 ). Using this scorecard, we found no correlation between an iPSC line's ability to establish NPCs and its predicted differentiation capacity into ectodermderived cell types or the expression of a broad set of endodermal and mesodermal markers ( Supplementary Figures 9 and 10 ). Taken together with the pluripotency marker analysis, teratoma formation assays and PluriTest assay results, these findings on all 12 of the iPSCs indicate that the BD patient iPSCs do not exhibit a general differentiation defect that could otherwise confound the interpretation of the deficits in neural differentiation that we observed.
Having established the capacity of all 12 of the Family-811 quartet iPSCs to differentiate into multiple cell lineages, we next sought to further establish the nature of the neurodevelopmental deficits that were observed. For this analysis, we again isolated total RNA from replicate cultures of fibroblasts, iPSCs, CXCR4 + (c) Volcano plots of (-Log10 (P-value) versus the Log2 (fold change expression)) of all genes (gray dots). Significant, differentially expressed genes (41.5-fold comparing BD cells with unaffected cells, moderated t-test P-value o0.05, Benjamini-Hochberg corrected) were plotted with orange dots with a subset annotated by gene name. Those genes that were also significant when members of the Family-811 quartet were compared based on sex (i.e. GM08329 versus GM8330, GM05225 and GM05225) were colored green. Gene expression differences were found to be enriched in the BD patient NPCs and neuronal populations. Each dot represents a gene expression assay (n = 3) for the cell type indicated. Error bars depict s.d. of the measurement. NPCs and 6-week differentiated neurons from the Family-811 quartet and used NanoString digital mRNA profiling to generate molecular signatures of each cell line using a custom 'PsychGene' probe set rather than the Bock scorecard. This PsychGene probe set was specifically designed to measure the expression of 352 genes and consisted of pluripotency genes, neural patterning genes, WNT pathway genes and genes implicated in the genetics of neuropsychiatric disorders ( Supplementary Table 7 ). Using principle component analysis to analyze the global PsychGene mRNA signature, we found that the respective cell types clustered together (Figure 4a ). Consistent with the results of this global analysis and our previous characterization of the iPSC properties, analysis of the expression of pluripotency and neural stem cell markers in all 12 iPSC lines confirmed the expected changes in expression of these genes when comparing the various cell differentiation states (Figure 4b ).
To better delineate the phenotypic defects in the BD patient cell lines from the Family-811 quartet, we then examined the average differences in gene expression of the BD patient cells relative to the unaffected parental control cells using the PsychGene NanoString probe set. Starting with the fibroblasts, examination of volcano plots in which the Log2(fold change) was plotted against the -Log10(P-value) revealed that only one gene, ZIC1 (ZIC family member 1), a C2H2-type zinc-finger transcription factor, met the criteria for a significant expression difference (fold change = 13.3, P-value = 0.04, Benjamini-Hochberg corrected) ( Figure 4c ). For iPSCs, there were no genes that exhibited a significant difference in expression between the six control lines and six BD patient lines. In sharp contrast to the lack of multiple differentially expressed genes in the fibroblasts and iPSC cell states, when comparing the expression profiles of the FACSpurified NPCs, there were 18 genes with significant expression differences between BD patient NPCs relative to unaffected parental control NPCs (41.5-fold change; P-value o 0.05, Benjamini-Hochberg corrected) (Figures 4c and 5a ). Among this set of differentially expressed genes in the BD patient NPCs were three genes encoding homeodomain-containing transcription factors, NKX2-2 (NK2 homeobox 2), NKX6-1 (NK6 homeobox 1) and IRX3 (iroquois homeobox 3), which are known to function in SHH (sonic hedgehog)-dependent neural patterning to specify the identity of ventral progenitor-derived neurons. In addition, several NPC-specific genes were differentially downregulated in the BD-patient NPCs: PAX6 (paired box gene 6a), DACH1 (dachshund homolog 1), and PLZF (promyelocytic leukemia zinc finger protein); ZBTB16 (zinc-finger and BTB domain containing 16), along with DISC1 (disrupted in schizophrenia 1), the latter of which has been shown to be critical for the regulation of neurogenesis and is implicated in the etiology of multiple neuropsychiatric disorders. 9, 11, 46, 47 To build on the differential gene expression signatures observed in the NPC state, we next analyzed the PsychGene NanoString profiles in postmitotic neurons that were differentiated for 6 weeks. As expected, there was an increased expression of the general neural differentiation markers DCX (doublecortin) and MAP2 (microtubule-associated protein 2), as well as the expression of multiple markers of upper and lower layer cortical projection neurons, including SATB2 (special AT-rich sequencebinding protein 2), CTIP2 (COUP TF-interacting protein 2; BCL11B), ETV1 (Ets variant gene 1), CUX1 (Cut-like homeobox 1) and RELN (Reelin) ( Supplementary Figure 11) . Comparison of the expression levels in BD patient neurons relative to their unaffected parental controls revealed that 28 genes in the PsychGene profiles were upregulated (41.5-fold change and P-value o0.05, Benjamini-Hochberg corrected), whereas 16 genes were downregulated (41.5-fold change and P-value o0.05, Benjamini-Hochberg corrected) (Figure 4c and Figure 5b ). Given the desire to gain insight into specific neuronal subtypes that may underlie alterations in the neurocircuitry affected in BD, analysis of the expression of markers of specific neuron subtypes revealed differential expression of only the cortical layer maker CTIP2 (BCL11B) and RELN, which were both significantly downregulated in the BD patient neurons compared with neurons from the unaffected parents (Figures 4c and 5b) , whereas numerous other markers of defined neuronal subtypes showed no difference ( Supplementary Figure 11 ). In this context, CTIP2 is notable as it is a component of the nucleosome remodeling and deacetylation (NuRD) complex, 48 which has a key role in the epigenetic regulation of neurogenesis 49 and the differentiation of cortical layer V/VI subcerebral projection neurons. 50 RELN, an extracellular matrix glycoprotein, in contrast, is involved in cortical neuron migration. 51 Taken together, these results provide further support for our hypothesis that differentiation into specific neural lineages is disrupted in the BD patient iPSCs when comparing FACSpurified CXCR4 + NPCs.
Having confirmed successful neural differentiation and observed differential gene expression among the BD patient CXCR4 + NPCs and neurons relative to unaffected parental controls, we sought to link these gene expression differences directly to known genetic risk factors for neuropsychiatric disorders. To do so, we first analyzed if several genes implicated by recent GWAS by the Psychiatric GWAS Consortium, 52-54 ANK3, CACNA1C, ODZ4 and ZNF804A, were differentially expressed in the Family-811 quartet cells. Although all four of these genes were expressed and exhibited increased expression after 6 weeks of neural differentiation, none were found to be differentially expressed between the BD patient and unaffected parent cells (Supplementary Figure 12 ).
Since we noted that a number of the genes were differentially expressed in both BD patients, CXCR4 + NPCs and their differentiated neuronal progeny, to obtain a global view of the patterns of gene expression, we used agglomerative hierarchical clustering to analyze a binary matrix of the total set of 53 significantly dysregulated genes. As shown in Figure 5c , a total of eight categories of genes were identified, including those such as SYN1, SCN2A (sodium channel, voltage-gated, type II, α subunit; Nav1.2), CNTN6 (contactin-6) and NKX2.2, which were upregulated in both cell states, as well as genes with opposite patterns of expression, such as PAX6, DCX and PLZF, which were downregulated in NPCs, but upregulated in neurons. Given that the latter three genes are all considered markers of neural progenitors, these data support the notion of the altered neurodevelopment upon directed differentiation of BD iPSCs.
Besides differential expression of neurodevelopmental genes, when analyzing the function of the other genes in the PsychGene NanoString profiles that showed significant expression differences, we noted that, consistent with prior genetic studies implicating calcium channel genes, 55, 56 five of the 34 (~15%) differentially expressed genes in the BD patient neurons were calcium channel or other ion channel subunits (Figure 5b) : CACNA1E (calcium channel, voltage-dependent, R-type, α1E subunit; Cav2.3), CACNA1G (calcium channel, voltage-dependent, T-type, α1G subunit; Cav3.1), CACNB1 (calcium channel voltage-dependent β1 subunit), a regulator of α-1 subunit membrane targeting and voltagedependent activation and inactivation, CACNG8 (calcium channel, voltage-dependent, γ subunit 8), a regulator of AMPA (α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid) receptor localization, the sodium channel genes SCN2A and SCN3A (sodium channel, voltage-gated, type III, α subunit; Nav1.3). However, owing to the fact that our NanoString PsychGene probe set was purposely biased in its construction for coverage of genes relevant to neurodevelopment and neuropsychiatric disorders, it was not possible to calculate whether there was significant enrichment of any given functional category of genes among the set of differentially expressed genes.
As an alternative approach to determining if there was evidence for common underlying molecular pathways, we turned to the consideration of the protein-protein interaction network among the proteins encoded by the differentially expressed genes. Using DAPPLE v.2.0, the set of the 53 differentially regulated genes were used as seed nodes and we built a direct and indirect (through other proteins) interaction network among the proteins encoded by the seed genes with edges between the nodes derived from protein-protein interaction data in the InWeb database of protein interaction that combines multiple data sources (MINT, BIND, IntAct, KEGG, ECrel, Reactome) as described by Lage et al. 57 ( Supplementary Figure 13A) . The statistical significance of the connectivity of individual proteins to other seed proteins, as well as a set of network connectivity parameters, was then assessed with within-degree, node-label permutation methods. Of the input 43 seed genes that could be mapped, nine proteins (MAP2, GPM6A, CACNA1G, CACNA1E, KLF4, CDH2, DACH1, SCN3A and SOX2) showed a statistically significant (P o0.05) connectivity after a 5000 within-degree, node-label permutation ( Supplementary Tables 8 and 9 ). Among the direct interactions between seed genes (Supplementary Figure 13B) , there were five protein pairs consisting of: (i) PAX6-SOX2; (ii) CTIP2-NR2F1 (nuclear receptor subfamily 2, group F, member 1); (iii) MAPT-NEFM; (iv) MAP2-CDH2; and (v) SCN2A-SNC3A, which was more than expected by chance alone (P = 0.04, 5000 permutations). In terms of the global network connectivity parameters, the network was composed of a total of 433 interactions from 220 unique proteins. Whereas the mean associated protein direct connectivity was not significant, the observed mean associated protein indirect connectivity (16.7; P = 0.0058, 5000 permutations) was nearly two times that expected. Taken together, these data support the hypothesis that there are shared functional pathways that are differentially regulated in the BD patient CXCR4 + NPCs and neurons compared with their parental controls. Furthermore, the network analysis points to specific physical protein-protein interaction networks that may be key mediators of the underlying phenotypic differences, including the transcription factors PAX6 and SOX2, the chromatin regulator CTIP2 and its direct interactor NR2F1, a member of the nuclear hormone receptor family of receptors, and the calcium channel subunits CACNA1G and CACNA1E.
Global transcriptome analysis of BD patient NPCs versus their parental controls To validate the differential expression of genes in the BD patientderived cells that was observed in the PsychGene NanoString profiles, and to characterize specifically the BD patient-derived cells in greater depth, we performed genome-wide, transcriptome analysis using RNA-seq to compare the BD patient CXCR4 + NPCs and parental control CXCR4 + NPCs, as this was the cell state that showed the earliest evidence of multiple robust phenotypic differences in the NanoString analysis. Total RNA was collected from each of the parental CXCR4 + NPC lines and replicate cultures of one of the BD patient CXCR4 + NPCs. Tophat was used to align raw RNA-seq reads to the Ensembl human Transcriptome, followed by Cuffdiff v.1.0 identification of differentially expressed genes from averaged reads from both parents and averaged reads from both replicates of the BD CXCR4 + NPCs. In total, 15 803 transcripts, including both coding and noncoding transcripts, were measured with sufficient coverage in both samples, of which 503 were found to have nominally significant differential expression (Po 0.05), which after correction for multiple hypothesis, a total of 35 were considered significantly expressed (P o 0.05, Benjamini-Hochberg) ( Supplementary Table 10 ).
Having these orthogonally generated mRNA quantification data, we sought to first cross-validate these data with our differentially expressed genes observed from the PsychGene NanoString molecular profiles of the CXCR4 + NPCs. As summarized in Supplementary Figure 14 , of the 15 genes analyzable by both methods, we observed concordant results for four (80%) of the five upregulated transcripts and six (60%) of the downregulated transcripts. Given the vastly different nature of the assays, with discrepancies being possible because of differences in transcripts and sensitivity of the methods, these results overall provide confidence in the reproducibility of the molecular profiles. Next, to determine whether the set of 503 transcripts covered any significantly overrepresented GO terms suggestive of common process and pathways, we analyzed the set using DAVIDv.6.7 bioinformatics software (Table 1 and Supplementary  Table 11 ). Of the 412 transcripts that could be mapped, 18 GO terms associated with the category of Biological Process were found to be significantly overrepresented (43 × ; P o0.05, Benjamini-Hochberg), with the most enriched being those concerning Neuron Differentiation, Development and Morphogenesis. At the same level of enrichment and significance, a total of six Cellular Compartment terms were overrepresented, including multiple terms covering the extracellular matrix and chromatin. Taken together, these data are overall supportive of our conclusions from the molecular profiling using the PsychGene Nano-String probe set that there are differences in the expression of genes important for neurodevelopment and neurogenesis in the BD patient CXCR4 + NPCs compared with their unaffected parental controls.
Using the set of 503 nominally significantly, differentially expressed transcripts as input seeds, we again constructed a protein-protein interaction network using DAPPLE v.2.0 (Supplementary Figure 15 ). Of the input 256 seed genes that could be mapped, 23 proteins showed statistically significant (P o0.05) connectivity after a 5000 within-degree, node-label permutation ( Supplementary Table 12 ). Among the direct interactions between seed genes, there were 113, which was more than expected by chance alone as evaluated by permutation testing (P = 0.0008). In terms of the global network connectivity parameters, the network was composed of a total of 5471 interactions between 1719 unique proteins, with both the observed mean associated protein direct connectivity (1.9; P = 0.045) and the observed mean associated protein indirect connectivity (89.5; P = 0.0002) significant with 5000 permutations ( Supplementary Figure 15 ). Taken together with the GO category analysis and similar analysis from using the PsychGene NanoString profiles, these data strongly support the hypothesis that there are shared functional pathways that are differentially regulated in the BD patients CXCR4 + NPCs compared with their parental controls.
Rescue of proliferation defects in BD patient NPCs with GSK3 inhibition
One gene identified as downregulated in the BD patient CXCR4 + NPCs in the RNA-seq profiles that was found to be significantly highly connected (P o0.005; 5000 permutations) within the DAPPLE network was that of WNT7B (wingless-type MMTV integration site family, member 7B), which had direct interactions with four other seed nodes consisting of two members of the frizzled family of seven-transmembrane receptors (FZD5, FZD7) and two soluble frizzled-related proteins (SFRP1, SFRP2) ( Figure 5e ). Collectively, the proteins within this module are known to have key roles in the regulation of WNT signaling, which is known as a critical mediator of neurogenesis, neurodevelopment and synaptic plasticity. Motivated by these observations, the previously observed differential expression of multiple WNT pathway components in both the PsychGene NanoString profiles (Figures 5a and b) , along with previous implication of WNT/GSK3 signaling in BD in part through the ability of lithium to activate WNT signaling, [12] [13] [14] we hypothesized that activation of WNT signaling through GSK3 inhibition would be sufficient to rescue the NPC proliferation deficits observed in the FACS-purified, BD-patient-derived CXCR4 + . In agreement with this notion, as shown in Figure 5f and Supplementary Figure 16 , treatment with CHIR-99021 (5 μM; 16 h), a highly selective and potent GSK3 inhibitor, 42, 58 led to a significant increase in BrdU incorporation in both BD patient NPC lines. In parallel, we assessed the response of the NPCs to CHIR-99021 treatment at the level of expression of known WNT pathway genes using our PsychGene NanoString probe set. As summarized in (Figure 5g ), CHIR-99021 treatment (5 μM; 16 h) increased the expression of the β-catenin target genes LEF1 (lymphoid enhancer-binding factor 1) and AXIN2 (axis inhibition protein 2), both of which are critical regulators of canonical WNT signaling. Taken together, these results suggest that WNT pathway activation can rescue the neurogenesis defects observed in the BD patient CXCR4 + NPCs from the Family-811 quartet.
Gene expression analysis of nEBs from Family-811 iPSCs To further corroborate our findings of differential gene expression between the BD patient CXCR4 + NPCs and neurons compared with their parental controls, and to overcome the limitation of having only one expandable CXCR4 + NPC line from each of the BD patient iPSCs, as an alternative differentiation method, we turned to the generation of nEBs formed from aggregating iPSCs under conditions that promote neuroectoderm formation (Supplementary Figures 17) . Whole-cell RNA was collected from multiple BD and unaffected nEBs at days 1 and 11. Using quantitative reverse transcription-PCR, as expected, neuralization resulted in increased expression of SOX1, a transcription factor that is an early maker of neuroectoderm formation, in both the unaffected and BD patient iPSC lines. In contrast, two of the BD patient nEBs failed to express PAX6, an evolutionarily conserved, homeobox-containing transcription factor downstream of SOX1 that has an essential role in balancing cortical neural progenitor proliferation and differentiation, 59, 60 whereas both unaffected parental lines upregulated PAX6 expression ( Supplementary Figure 17 ). This downregulation of PAX6 expression in the BD patient nEBs was in agreement with the reduced PAX6 expression observed by the NanoString profiles in the FACS-isolated CXCR4 + NPCs and by RNA-seq (Figure 5a and Supplementary Figure 14 ). Taken together, these data suggest that the dysregulation of PAX6 expression, a key regulator of corticogenesis, contributes to the neural differentiation deficit of the BD patient iPSCs from Family-811.
Upon observing aberrant expression of the NPC marker PAX6 in the BD patient nEBs, we next tested an expanded set of 48 genes consisting of differentially expressed genes identified from our PsychGene NanoString assays of the FACS-purified CXCR4 + NPCs along with WNT, NOTCH and SHH pathway genes using the Fluidigm BioMark HD system ( Supplementary Figures 18 and 19 and Supplementary Table 13 ). As expected, pluripotency genes, SOX2, OCT4 and NANOG, were repressed upon nEB formation to similar extents comparing the BD and unaffected parental iPSCs. Significant differential expression of NKX6-1, LEF1, NEUROG1, NRG3 and SPARCL1 in the BD nEBs relative to the unaffected parental controls was observed ( Supplementary Figures 18 and 19 ). Taken together with the results from the analysis of the CXCR4 + NPCs using NanoString and RNA-seq, these findings provide further evidence for differential gene expression upon induction of neurodevelopment in the BD patient-derived cells compared with their parental controls from Family-811.
DISCUSSION
A number of issues inherent to modeling complex, polygenic diseases with patient-derived stem cells complicate the unambiguous association of in vitro phenotypes with disease pathogenesis.
Most notably, given the complex genetic architecture, potential genetic diversity of each individual cell line, and also the technical variability in the isolation of iPSC lines, the studies performed to date, including those described here, have all been underpowered to rigorously test the hypotheses about disease etiology and the relationship of specific genetic variants to cellular phenotypes.
In this work, we sought to simplify the question of genetic diversity by using genetically related individuals rather than genetically unrelated cases and controls under what we consider a family-based paradigm for iPSC modeling of a complex human genetic disorder. To this end, we generated clonally independent iPSCs (rather than clones derived from the same founding cell line), as well as highly purified, expandable, CXCR4 + NPCs from multiple members of the same family with unaffected and BD individuals. This family-based paradigm, using a pedigree enriched for neuropsychiatric phenotypes, 43 has the advantage of controlling for the genetic background, and enhancing the chance that both affected individuals share the same underlying BD etiology. In the future, as higher-throughput methods for iPSC generation are brought to bear, following such a paradigm will allow the field to carry out more adequately powered studies. Given the density of psychopathology found within the pedigree of Family-811, from which the nuclear family we reprogrammed was derived, a priority for the future should be to reprogram additional family members for which fibroblasts already exist to determine whether other family members with BD exhibit the same phenotypes relative to other unaffected family members.
Overall, our phenotypic characterization of the two affected BD sons to their unaffected parents at the level of cellular and molecule profiles revealed a number of significant and consistent differences (summarized in Supplementary Table 14 ). Given the neurodevelopmental phenotypes we observed in the BD iPSCs relative to their parental controls, of paramount importance to the interpretation of these results was to demonstrate that the BD iPSCs did not exhibit generic differences in their pluripotency and capacity to differentiate into other non-neuronal tissues. We addressed this potential concern for all 12 iPSC lines in three ways: (1) demonstrating the expression of a panel of appropriate pluripotency markers through immunostaining and mRNA assays;
(2) demonstrating the capacity to form multiple germ layers through in vivo teratoma formation; and (3) genome-wide expression profiling and the use of PluriTest as a computational method to benchmark our iPSCs to other pluripotent stem cells. After first establishing the pluripotency of all three iPSCs generated from each of the Family-811 quartet members through multiple methods, and demonstrating a lack of an overall differentiation deficit into multiple germ layers, our results point to specific defects in this family in the development, establishment or maintenance of NPCs, potentially due to the dysregulation of PAX6, an essential regulator of neurogenesis and corticogenesis.
Although the generalizability of these observations will require the creation of iPSCs from additional BD patients, which is ongoing, two other studies in the context of psychiatric disorders that described the isolation of similar NPCs did not describe phenotypic defects in these types of cells. 27, 61 While this manuscript was under revision, a study by Chen et al. 62 described a set of BD patient-derived iPSCs. Although Chen et al. 62 did not characterize phenotypes of BD NPCs, when differentiated neuronal cells derived from neuronal rosettes were examined, encouragingly several gene expression changes that overlap with those identified in our iPSC-derived cells from Family-811 were observed. First, PAX6 gene expression was altered in both studies: Chen et al. 62 showed that PAX6 expression was decreased in BD patient neurons; our data suggest that PAX6 expression is decreased in BD patient NPCs, but in our studies PAX6 expression increased upon further differentiation into neurons (Figures 5a  and b ). Although the direction of the PAX6 effect in neurons is different, both of these BD iPSC studies are consistent with there being an alteration in the normal fate of neuronal differentiation in BD iPSCs. These differences may arise from the use of a different neuron/NPC differentiation protocol as in Chen et al., 62 control and BD neurons were derived from iPSC aggregates in which neural induction was performed using dual SMAD inhibition with subsequent manual passaging and expansion of rosettes followed by differentiation into neurons; our NPC derivations begin in a monolayer and did not use dual SMAD inhibition. Alternatively, these differences may be inherent to the particular BD patients investigated. Similar to our results, Chen et al. 62 also identified changes in the calcium channel subunit CACNA1E, although once again the direction of the change was different. Our data also suggest that other calcium channel subunits are altered (e.g. CACNA1E, CACNA1G, CACNB1, CACNG8; Figure 5b ), consistent with calcium signaling being altered in neurons from BD patients. Another similarity in the gene expression data were FGF14 levels: both studies show that FGF14 levels are increased in BD neurons. FGF14 is a nonsecreted FGF that associates with sodium channel complexes [63] [64] [65] [66] and regulates their function along with the function of presynaptic calcium channels. 67 Furthermore, FGF14 localizes at the axonal initial segment, where Ankyrin G (encoded by ANK3), a BD risk gene, clusters sodium channels. 64, 68 Lastly, these FGF14/sodium channel complexes have been shown to be regulated by GSK3, 69 a target of the BD therapeutic lithium and the inhibitor CHIR-99021 used in our study to rescue the proliferation deficit seen in BD patient NPCs. Although these gene expression data suggest a functional connection between FGF14 and other BD risk-associated genes, there has been, to date, no significant genetic association between FGF14 and bipolar disorder risk in the Psychiatric GWAS consortium's (PGCBDW Group) analysis. 52 Nevertheless, taken together, these consistent gene expression changes and functional themes suggest that there may be several connections between genes altered in iPSCderived BD neurons and other risk-associated genes and pathways that implicate calcium signaling and axonal initial segment function as nodes of integration of BD pathogenesis.
Besides the cellular-level phenotypic differences in NPC formation and neurogenesis, at the molecular level several groups of differentially expressed genes were observed, further supporting the notion of neurodevelopmental abnormalities in the BD patient NPCs and neurons. Of note, CNTN6 (NB-3), a cell adhesion molecule also implicated in autism, 70 which has shown modest association (rs3772277; P = 0.000126) with BD in the Psychiatric GWAS Consortium study, 52 and was significantly associated with a BD subgroup with comorbidities in the GAIN cohort 71 (rs2727943; P = 3.3 × 10 − 8 ), was among the most differentially expressed genes in both the NanoString and RNA-seq profiling (Figures 4c and 5a and b). Previous work suggests that CNTN6 has a role in the maturation of oligodendrocyte progenitors through its interaction with Notch1, a key regulator of neurogenesis, 72 potentially pointing to perturbation of oligodendrocyte development in the BD patient iPSCs. Future studies aimed in investigating whether there are oligodendrocyte abnormalities in these and other BD iPSC models is warranted. Finally, several results from our studies suggest WNT signaling is perturbed in the neural cells from the two BD affected sons. First, in both our NPCs and nEBs, we identified multiple genes involved in WNT signaling that were differentially expressed between the BD and parental lines. Second, rescue of the proliferation defect in the BD patient NPCs from Family-811 upon treatment with CHIR-99021, a highly potent, and selective GSK3 inhibitor, 42 suggest that dysregulation of the WNT pathway may underlie at least a subset of the phenotypic differences observed in the BD patient NPCs. Given the ability of the BD therapeutic lithium to activate WNT signaling, these findings support the notion that targeting the WNT/GSK3 pathway may provide an important direction for the development of novel therapeutics for BD. 73 In summary, with the generation of this set of 12 iPSCs along with a set of representative expandable NPC lines for the first time from a family with BD, our studies have established a new paradigm and resource for gaining insight into the etiology and pathogenesis of BD. Collectively, our phenotypic comparisons present numerous avenues for future investigation through the implication of abnormalities in early steps in NPC formation, WNT/ GSK3 signaling and ion channels expression in the BD patientderived NPCs and neurons. Future expansion of these studies to include samples from additional families and well-phenotyped patients along with appropriately selected controls holds tremendous promise for helping elucidate fundamental mechanisms of human disease biology and for presenting a new path for translating basic research into novel therapeutic discoveries for BD. 73 
